SARS-CoV-2 Infection as a Trigger for Telogen Effluvium: A Literature Review with Case-Based Clinical Evaluation Guidance

The document is a review of literature and a case study on Telogen Effluvium (TE), a temporary hair loss condition triggered by SARS-CoV-2 infection (COVID-19). The document suggests that COVID-19 can cause TE due to the physiological stress it places on the body. A case study of a 48-year-old female patient showed complete hair recovery after eight months of treatment with vitamin supplements, topical Minoxidil 2% solution, and hair-fortifying shampoos, along with psychological support. The document also discusses various studies, one of which found that 25% of COVID-19 patients experienced alopecia during recovery. Another study showed that TE typically starts 45 days after infection and lasts for an average of 47.5 days. The document concludes that TE post-COVID-19 is a common but reversible condition with appropriate dermatological treatment.